Fab Biopharma is pioneering drug discovery to improve female health. Built by industry veterans with specialized expertise in drug discovery and development, clinical development, commercial strategy and IP, Fab Biopharma is developing a novel class of bispecific soluble receptors to simultaneously target T and B cell-activating cytokines and ligands.